However, HIF-1α also promotes carcinogenesis and is a prominent cancer target, and various HIF-1α inhibitors have been identified and are currently being studied for their efficacy in cancer therapy (Chou et al., 2016). The gene discussed is HIF1A; the disease is cancer.